Elevation Pharma reports positive phase II b results for EP-101 in COPD patients - pharmabiz.com
18 May 2012, 4:17 am
Compared to other nebulization technologies, eFlow Technology produces aerosols with a very high density of active drug, a precisely defined droplet size, and a high proportion of respirable droplets delivered in the shortest possible period of time.